$AXGN News

AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam

Axogen, Inc. (NASDAQ:AXGN) Analysts Are Pretty Bullish On The Stock After Recent Results

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

Citizens Maintains Market Outperform on Axogen, Raises Price Target to $50

Wells Fargo Maintains Overweight on Axogen, Raises Price Target to $48

HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $50

Axogen Inc (AXGN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses

Axogen (AXGN) Q3 2025 Earnings Transcript

Axogen (AXGN) Q1 2025 Earnings Transcript

Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript

AxoGen Q1 Earnings Call Highlights

Axogen Inc (NASDAQ:AXGN) Rallies on Q1 Revenue Beat and Raised 2026 Guidance

AxoGen (AXGN) Q1 Earnings Lag Estimates

Axogen, Inc. Reports First Quarter 2026 Financial Results

Axogen, Inc. 2026 Q1 - Results - Earnings Call Presentation

Full Transcript: Axogen Q1 2026 Earnings Call

Axogen shares are trading higher after the company reported better-than-expected Q1 sales results.

Axogen FY2026 Revenue Expected To Be At Least $270.000M vs $266.219M Est

Axogen Q1 Adj. EPS $0.07, Inline, Sales $61.457M Beat $57.725M Estimate

Is It Too Late To Consider Axogen (AXGN) After Its 1‑Year Share Price Surge?